These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34048879)

  • 21. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye.
    Bisht R; Jaiswal JK; Rupenthal ID
    Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depthwise-controlled scleral insertion of microneedles for drug delivery to the back of the eye.
    Park SH; Jo DH; Cho CS; Lee K; Kim JH; Ryu S; Joo C; Kim JH; Ryu W
    Eur J Pharm Biopharm; 2018 Dec; 133():31-41. PubMed ID: 30267835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progesterone PLGA/mPEG-PLGA Hybrid Nanoparticle Sustained-Release System by Intramuscular Injection.
    Xie B; Liu Y; Guo Y; Zhang E; Pu C; He H; Yin T; Tang X
    Pharm Res; 2018 Feb; 35(3):62. PubMed ID: 29445971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cationic polymer modified PLGA nanoparticles encapsulating Alhagi honey polysaccharides as a vaccine delivery system for ovalbumin to improve immune responses.
    Wusiman A; Gu P; Liu Z; Xu S; Zhang Y; Hu Y; Liu J; Wang D; Huang X
    Int J Nanomedicine; 2019; 14():3221-3234. PubMed ID: 31123399
    [No Abstract]   [Full Text] [Related]  

  • 25. Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis.
    Permana AD; Tekko IA; McCrudden MTC; Anjani QK; Ramadon D; McCarthy HO; Donnelly RF
    J Control Release; 2019 Dec; 316():34-52. PubMed ID: 31655132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapidly Dissolving Trans-scleral Microneedles for Intraocular Delivery of Cyclosporine A.
    Alrbyawi H; Annaji M; Fasina O; Palakurthi S; Boddu SHS; Hassan N; Tiwari AK; Suryawanshi A; Babu RJ
    AAPS PharmSciTech; 2024 Feb; 25(2):28. PubMed ID: 38302687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rational Design of PLGA Nanoparticle Vaccine Delivery Systems To Improve Immune Responses.
    Gu P; Wusiman A; Zhang Y; Liu Z; Bo R; Hu Y; Liu J; Wang D
    Mol Pharm; 2019 Dec; 16(12):5000-5012. PubMed ID: 31621331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye.
    Huu VA; Luo J; Zhu J; Zhu J; Patel S; Boone A; Mahmoud E; McFearin C; Olejniczak J; de Gracia Lux C; Lux J; Fomina N; Huynh M; Zhang K; Almutairi A
    J Control Release; 2015 Feb; 200():71-7. PubMed ID: 25571784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fast-dissolving microneedle array loaded with chitosan nanoparticles to evoke systemic immune responses in mice.
    Li Z; He Y; Deng L; Zhang ZR; Lin Y
    J Mater Chem B; 2020 Jan; 8(2):216-225. PubMed ID: 31803892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Photopolymerized Semi-Interpenetrating Polymer Networks-Based Hydrogel Incorporated with Nanoparticle for Local Chemotherapy of Tumors.
    Wang Y; Li Q; Zhou JE; Tan J; Li M; Xu N; Qu F; Chen J; Li J; Wang J; Liang Z; Yu L; Wang Y; Yan Z
    Pharm Res; 2021 Apr; 38(4):669-680. PubMed ID: 33796952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery.
    Thalhauser S; Peterhoff D; Wagner R; Breunig M
    Eur J Pharm Biopharm; 2020 Nov; 156():1-10. PubMed ID: 32860903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization.
    Mittal A; Raber AS; Schaefer UF; Weissmann S; Ebensen T; Schulze K; Guzmán CA; Lehr CM; Hansen S
    Vaccine; 2013 Jul; 31(34):3442-51. PubMed ID: 23290836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
    Durgun ME; Güngör S; Özsoy Y
    J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-step solid-oil-water emulsion for sustained bioactive ranibizumab release.
    Chua HY; Lui YS; Bhuthalingam R; Agrawal R; Wong T; Preiser PR; Venkatraman S
    Expert Opin Drug Deliv; 2018 Dec; 15(12):1143-1156. PubMed ID: 30354700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of nanoencapsulation using poly (lactide-co-glycolide) (PLGA) on anti-angiogenic activity of bevacizumab for ocular angiogenesis therapy.
    Zhang XP; Sun JG; Yao J; Shan K; Liu BH; Yao MD; Ge HM; Jiang Q; Zhao C; Yan B
    Biomed Pharmacother; 2018 Nov; 107():1056-1063. PubMed ID: 30257317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of dissolving microneedles for intradermal delivery of the long-acting antiretroviral drug bictegravir.
    Zhang C; Vora LK; Tekko IA; Volpe-Zanutto F; Peng K; Paredes AJ; McCarthy HO; Donnelly RF
    Int J Pharm; 2023 Jul; 642():123108. PubMed ID: 37301241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization.
    Kim J; Lima E Silva R; Shmueli RB; Mirando AC; Tzeng SY; Pandey NB; Ben-Akiva E; Popel AS; Campochiaro PA; Green JJ
    Acta Biomater; 2019 Oct; 97():451-460. PubMed ID: 31374338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.